3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Cognitive Dysfunction
1
Chemotherapy-Related Cognitive Impairment
1
Interventions
Tobacco Use Cessation Devices
1
Sodium Chloride
1
Mesna
1
Electroacupuncture
1
Doxorubicin
1
Cyclophosphamide
1
Ashwagandha
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Chemotherapy-Related Cognitive Impairment
×
Ashwagandha
×
Clear all
NCT04092647
2023-06-15
Ashwagandha for Cognitive Dysfunction
Sutter Health
Phase 2
Unknown
80 enrolled